AmnioBand® Particulate is an aseptically processed human allograft placental matrix comprised of amnion and chorion for use as an acute or chronic wound covering.
• Maintains inherent growth factors and matrix proteins essential to wound healing and host tissue remodeling
• Maximizes surface coverage
• Configuration allows for optimal contouring to complex topographies
• Aseptic processing preserves tissue's natural structure
• Ready right out of the package
• Can be used in the hydrated or dehydrated state
• Available in multiple sizes
• Three year shelf life at ambient temperature
AmnioBand® Particulate is an allograft membrane covering for wounds, including use as a covering for the surgical site. It is intended for single use only.
The presence of severe vascular compromise, active or latent infection, or uncontrolled infection may compromise the usefulness of the tissue.
Do not sterilize. Prescription use only. No known sensitizing agents are present in this tissue. NOTE: No antibiotics were used in the manufacturing process.
Do not use if container seal is not intact or damaged, if container label or identifying barcode is severely damaged, not legible, or missing, if expiration date shown on container label has passed. AmnioBand® Particulate should be stored at ambient temperature. Do not refrigerate or freeze. It is the responsibility of the transplant facility or clinician to maintain the tissue intended for transplantation in the appropriate recommended storage conditions prior to transplant.
Extensive medical screening procedures have been used in the selection of all tissue donors for MTF (please see Donor Screening and Testing). Transmission of infectious diseases such as HIV or hepatitis, as well as a theoretical risk of the Creutzfeldt-Jakob (CJD) agent, may occur in spite of careful donor selection and serological testing
Possible adverse effects of using human tissues include but are not limited to: infection of soft tissue and/or bone (osteomyelitis), fever, disease transmission and undesirable immune response
Store at ambient temperature. Do not refrigerate or freeze.
|Shelf life greater than 2 years||●|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Variety of sizes||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Moderate/Highly Exudating Wounds
Non/Minimally Exudating Wounds
AmnioBand® Particulate's inner bottle and the outer foil pouch are sterilized. Use standard aseptic/sterile technique to open the package and make it ready for use.
Peel open the foil pouch and transfer the inner bottle as a single unit into the sterile field. Remove the white cap and aluminum collar from the bottle. Remove the rubber stopper. Note: The container shall be held firmly on a hard surface while removing stopper to prevent spillage. Apply AmnioBand® Particulate directly to the patient site. If needed the particulate may be hydrated with sterile saline prior to or after application.
Note: Ensure the wound site is free of debris and necrotic tissue and debride if necessary prior to graft placement. Once the foil pouch is opened, tissue should be used promptly. Innermost bottle alone is not intended for storage of tissue, as it may not provide an adequate moisture or sterile barrier.
Note: The tissue must be implanted or discarded within 24 hours of opening the tissue container provided the allograft tissue is maintained in an aseptic environment.
Dressings covering AmnioBand® Particulate should be changed weekly or as needed.
Primary Dressing: AmnioBand® Particulate should be covered with a non-adherent dressing.
Secondary Dressing: AmnioBand® Particulate requires a moist wound environment. Use appropriate moisture management dressings for the wound type and treatment ideology.
To further encourage healing, patient should be appropriately off-loaded following each visit as per institution's standard protocols.
MTF Wound Care is dedicated to developing highly advanced, safe, clinically-based, and cost-effective wound care solutions that work in concert with the body's natural healing process. MTF Wound Care is a division of the Musculoskeletal Transplant Foundation (MTF).